{
    "id": "dbpedia_2040_2",
    "rank": 26,
    "data": {
        "url": "https://cdn.yahoofinance.com/prod/sec-filings/0001574565/000117891324001488/exhibit_99-3.htm",
        "read_more_link": "",
        "language": "en",
        "title": "",
        "top_image": "",
        "meta_img": "",
        "images": [],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "",
        "meta_lang": "",
        "meta_favicon": "",
        "meta_site_name": "",
        "canonical_link": null,
        "text": "FOR\n\nAGAINST\n\nABSTAIN\n\n1.\n\nRe-election of each of the below-listed directors, until the Company’s next annual general meeting of shareholders and until his or her successor is duly elected and qualified:\n\n(a) Ms. Sarit Firon\n\n☐\n\n☐\n\n☐\n\n(b) Dr. Adrian Percy\n\n☐\n\n☐\n\n☐\n\n(c) Mr. Leon Y. Recanati\n\n☐ ☐ ☐\n\n(d) Prof. Oded Shoseyov\n\n☐ ☐ ☐\n\n(e) Mr. Dan Falk\n\n☐ ☐ ☐\n\n(f) Mr. Nir Nimrodi\n\n☐ ☐ ☐ 2.\n\nTo approve a reverse share split of the Company’s ordinary shares in the range of 2:1 up to 20:1, to be effected at the discretion of, and at such ratio and in such date as shall be determined by, the Board of Directors of the Company, within 12 months of the Meeting; and to amend the Company’s Articles of Association accordingly.\n\n☐ ☐\n\n☐\n\n3.\n\nAdoption of a new compensation policy for the Company’s office holders (as defined under the Israeli Companies Law, 5759-1999, or the Companies Law).\n\n☐ ☐ ☐ 3A.\n\nAre you a controlling shareholder or do you have a personal interest in the approval of Proposal 3? (Please note: If you do not mark either ‘FOR’ or ‘AGAINST’, or otherwise contact the Company, we will assume that you are not a controlling shareholder and do not have a personal interest in the approval of Proposal 3).\n\n☐ ☐ ☐ 4.\n\nApproval of the grant of options to purchase 500,000 of the Company’s Ordinary Shares to the Company’s President and Chief Executive Officer, Mr. Ofer Haviv.\n\n☐ ☐ ☐ 4A.\n\nAre you a controlling shareholder or do you have a personal interest in the approval of Proposal 4? (Please note: If you do not mark either ‘FOR’ or ‘AGAINST’, or otherwise contact the Company, we will assume that you are not a controlling shareholder and do not have a personal interest in the approval of Proposal 4).\n\n☐\n\n☐\n\n☐"
    }
}